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static melanoma. LA, Left atrium; RA, right atrium; RV, right ventricle; LV,
left ventricle.Ocular melanoma is diagnosed in approximately 6 mil-lion people annually.1 Although ocular melanomametastasizes less frequently than cutaneous mela-noma (75% vs 96%, respectively), when it does me-
tastasize, it is invariably fatal, usually within 1 year of the onset of
symptoms.2 Even though the liver is the most common location for
metastases from ocular melanoma, it is thought that the heart is
another common site that is clinically underdiagnosed.
Clinical Summary
A 75-year-old white man presented in the fall of 2000 with abdominal
pain and shortness of breath. A thorough workup revealed an invasive
adenocarcinoma of the cecum. A right hemicolectomy was performed
on April 10, 2001, during which a biopsy of a liver lesion identified
on computed tomographic (CT) scan was reported to show a meta-
static adenocarcinoma. In June 2001, a resection of the left hepatic
lobe and placement of an intrahepatic arterial pump were performed
to treat what was thought to be metastatic colon cancer. The patho-
logic results later indicated that the left hepatic lesion was melanoma.
Throughout this patient’s course, physical examination did not reveal
any suggestive skin lesions. A review of the patient’s history revealed
that ocular melanoma of the right eye had been diagnosed 15 years
earlier, and he underwent enucleation at another center. Routine
fluorodeoxyglucose positron emission tomography (FDG-PET) and
CT scans were unremarkable until March 2005, when the FDG-PET
scan revealed a hypermetabolic soft tissue mass in the myocardium of
the apex of the left ventricle measuring 24  35 mm (Figure 1, A,
axial, and B, coronal). A subsequent contrast-enhanced CT (Figure 1,
A), echocardiogram (Figure 1, C), and cardiac magnetic resonance
imaging (MRI) (Figure 1, D) corroborated this finding.
Cardiac surgery with cardiopulmonary bypass was performed
during which an obvious melanotic mass emanating from just to
the left of the left anterior descending artery and approximately 2
cm from the true apex of the heart was found. A sharp dissection
was performed with all margins grossly negative. The myocardium
resected included parts of the septum, the left ventricle, and the
right ventricle. The mass was diagnosed as a cardiac metastasis
from ocular melanoma (Figure 2, A and B).
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The Journal of ThoracicFigure 1. A, Combined axial contrast-enhanced computed tomography
(CT) and corresponding fluorodeoxyglucose positron emission tomogra-
phy (FDG-PET) image shows a 3.2 cm 3.1 cmmass in the region of the
cardiac apex, which is isodense to muscle tissue during the arterial
contrast phase. This mass involves the left ventricle and cardiac sep-
tum. B, FDG-PET in March 2005 (B: coronal) revealed a new hypermeta-
bolic soft tissuemass in the myocardium of the apex of the left ventricle
measuring 24 35 mm. There was no other evidence of metabolically
active disease. C, Apical 4-chamber echocardiogram revealed an ap-
parent extracardiac mass (arrows) adjacent to the LV apex. The dimen-
sions of the mass were 4.3  2.6 cm. D, Cardiac magnetic resonance
imaging (MRI) showing a mass measuring 4  2.5  2 cm, which is
described as heterogenous but overall bright in image intensity on
true-FISP imaging (fast imaging with steady-state precession) before
contrast administration, and it did not appear to involve the pericardium.
Delayed enhancement imaging demonstrated hyperenhancement of the
mass, and perfusion imaging revealed that the mass had a very short TI
even before administration of gadolinium contrast, suggestive of meta-and Cardiovascular Surgery ● Volume 130, Number 6 1727
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When ocular melanoma metastasizes, liver involvement is most
frequent (90%) followed by lung, skin, bone, thyroid, breast,
ovary, adrenal gland, lungs, subcutaneous tissue, lymph nodes, and
the central nervous system.1,3,4 In terms of cardiac metastases,
early reports suggested that such metastases from ocular mela-
noma are extremely uncommon.3 A later report by Mäkitie and
Kivelä5 suggested that although cardiac metastases from ocular
melanoma are indeed clinically underdiagnosed, autopsy reviews
indicated that cardiac metastases from ocular melanoma are not
uncommon, with 19% to 24% of patients who die of disseminated
ocular melanoma having cardiac metastasis at autopsy. Typically,
these cardiac metastases involve the pericardium and myocardium,
and only rarely involve the endocardium or the valves.4 The
location of this patient’s cardiac mass in the left side of the heart
is notable because left-sided cardiac involvement is less common.4
Melanoma is thought to reach the heart most often through hema-
togenous spread, as in the case of our patient.4 Removal of a
cardiac metastasis carries with it the risk of myocardial rupture, as
occurred in the case reported by Rosario and colleagues.4 In that
report, the mass measured 6.2 3.2 cm compared with a 4.9 3.2
 2.2 cm mass that was successfully removed in our patient.4
Cardiac metastases from melanomas are generally diagnosed
by echocardiography.6 Newer detection modalities include mag-
netic resonance imaging, CT, and PET, which all have established
use in detecting distant metastases in patients with melanoma. PET
is a helpful, noninvasive imaging technique that is being used
today for staging of melanoma and has potential for use in access-
ing response to treatment. In a study performed in 1998, Holder
and coworkers7 reported that PET had an overall sensitivity and
specificity of 94.2% and 83.3%, respectively, in contrast with
55.3% and 84.4%, respectively, for CT in the detection of meta-
static disease in melanoma, especially in the liver, soft tissues, and
lymph nodes.8
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On the basis of a review of the literature and this distinct case, we
suggest a vigilant approach to screening patients with a melanoma
diagnosis. Diagnosis of cardiac metastasis is especially difficult
because patients are often clinically asymptomatic when treatment
would be most effective.5 Many of them are generally older and
have concurrent heart disease, which may obscure clinical and
electrocardiogram findings that otherwise would indicate a cardiac
metastasis.5 Taking advantage of presently available screening
modalities (echocardiogram, CT, cardiac MRI, and PET) may lead
to earlier diagnosis of metastases, particularly cardiac, leading to
more positive outcomes.
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Figure 2. A, Hematoxylin-eosin stain, 2.5:
Resected specimen: 25 g, 5.4  3.5  3.3 cm
fragment of tan muscle tissue. Sectioning re-
vealed a 4.9  3.2  2.2 cm soft, black mass
throughout the muscle tissue and extending
to the epicardium. B, Hematoxylin-eosin
stain, 50: Microscopically, large amounts of
pigment present throughout the tumor; nuclei
are large and pleomorphic with large areas of
tumor necrosis.242-53.
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